Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 143 results for "lacosamide"

Marksans gets USFDA approval and other top pharma news
India Infoline

Marksans gets USFDA approval and other top pharma news

Alembic Pharma said that it has received final approval from the US health regulator for Lacosamide tablets, used for treatment of partial-onset seizures, in the American market. (FC) Marksans Pharma said on Monday that it has received approval from the US ... India Infoline, 2 days ago
PHARMA-ALEMBIC PHARMA-USFDA NOD United News of India, 3 days ago

Glenmark receives tentative US FDA approval for lacosamide oral solution

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (US FDA) for its lacosamide oral solution, 10 mg/ml, the generic version of Vimpat Oral Solution, 10 mg/ml of UCB, Inc.
 PharmaBiz1 month ago Glenmark Pharma gets tentative ANDA approval for Lacosamide oral solution  Money Control1 month ago Glenmark Pharma gets tentative USFDA nod for Lacosamide Oral Solution [India Infoline News Service]  Pharmacy Choice1 month ago Glenmark gets tentative nod from USFDA for epilepsy drug  Economic Times1 month ago

Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval for Lacosamide Tablets (VimpatĀ®)

BOCA RATON, Fla. , May 3, 2016 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that Breckenridge and MSN Laboratories Private Limited were granted final approval for their ANDA lacosamide tablets, 50 mg, 100 mg, 150 mg and 200 mg.
 Minyanville1 day ago Breckenridge Pharmaceutical Announces Final ANDA Approval for Lacosamide Tablets (Vimpat)  FirstWord Pharma18 hours ago

New and Generic Drug Approvals: Lacosamide

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to
 U.S. Food and Drug Administration12 hours ago
Monthly Prescribing Reference

Long-Term Lacosamide Given Alone Thwarts Partial-Onset Seizures: Presented at AAN

You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 16 days for your content allowance to be renewed. Sign up for a free trial to ...
 FirstWord Pharma2 weeks ago Lacosamide Monotherapy Up to 800mg Safe for Partial-Onset Seizures  Monthly Prescribing Reference2 weeks ago
Financial Express

Aurobindo Pharma shares surge 5% on USFDA approval for epilepsy drug

Aurobindo Pharma shares advanced over 5 per cent on Tuesday after the pharma company announced that it has received US Food & Drug Administration (USFDA) approval for its epilepsy prevention drug Lacosamide.(Reuters) Aurobindo Pharma shares ...
 Financial Express2 days ago Aurobindo Pharma gains as Credit Suisse initiates coverage  Economic Times2 days ago Aurobindo Pharma shares surge on USFDA approval for epilepsydrug  Yahoo! India1 day ago
Business Today India

Sensex cuts entire gains to end 207 points lower

The S&P BSE Sensex on Tuesday wiped off all gains to end the day 207 points down, while broader CNX Nifty settled the day below its key 7,750-mark. The headline indices surrendered earlier gains tracking subdued Asian stock markets as weak China ...
 Business Today India1 day ago Sensex slides 207 points on global growth worries, Nifty settles below 7,750; TVS Motor tanks 10%  Financial Express2 days ago Live Stock Market Updates Nifty ends down 0.56%  India Infoline3 days ago Sensex slips 170 points on weak manufacturing data, disappointing Q4 results  Financial Express3 days ago

FDA approves Aurobindo's epilepsy drug

Singapore: The US Food & Drug Administration (USFDA) has granted approval for Aurobindo Pharma's epilepsy prevention drug Lacosamide. Aurobindo Pharma is India's leading drugmaker. Epilepsy is the fourth common neurological disorder that affects ...
 Bio Spectrum Asia2 days ago Aurobindo Pharma gains on USFDA approval for epilepsy drug  Sify2 days ago
Financial Express

TVS Motors, Aurobindo Pharma among 7 stocks that remained in focus today

TVS Motor shares closed 9.66 per cent down at Rs 287.90 despite posting 30.09 per cent rise in its net profit figures at Rs 117.76 crore for the quarter ended March 2016. It has posted a net profit of Rs 90.52 crore in the same quarter last year.
 Financial Express2 days ago Stocks in focus: Tata Motors, Hero MotoCorp, HDFC, Aurobindo  Hindu Business Line2 days ago Top 12 stocks in focus today: Tata Motors, Adani Ports, NALCO  India Infoline2 days ago
Financial Express Bangladesh

Sensex sheds 207 points as China factory data rekindles global growth worries

Indian shares surrendered earlier gains and closed lower for a second straight session on Tuesday, tracking subdued regional stock markets as weak China factory data rekindled global growth worries. The broader NSE index fell 58.9 points or 0.75 ...
 Hindu Business Line2 days ago Indian shares slip on global growth worries  Financial Express Bangladesh2 days ago Sensex falls on global growth worries, weak China data  Yahoo! India2 days ago Indian shares fall on global growth worries, weak China data  Reuters UK2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - lacosamide
Get updated on latest news & your favorite topics right in your inbox!
More     Less